Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway

  1. Annie Wai Yeeng Chai
  2. Pei San Yee
  3. Stacey Price
  4. Shi Mun Yee
  5. Hui Mei Lee
  6. Vivian KH Tiong
  7. Emanuel Gonçalves
  8. Fiona M Behan
  9. Jessica Bateson
  10. James Gilbert
  11. Aik Choon Tan
  12. Ultan McDermott
  13. Mathew J Garnett
  14. Sok Ching Cheong  Is a corresponding author
  1. Cancer Research Malaysia, Malaysia
  2. Wellcome Trust Sanger Institute, United Kingdom
  3. Wellcome Trust Genome Campus, United Kingdom
  4. Moffitt Cancer Center, United States
  5. AstraZeneca, United Kingdom

Abstract

New therapeutic targets for oral squamous cell carcinoma (OSCC) are urgently needed. We conducted genome-wide CRISPR-Cas9 screens in 21 OSCC cell lines, primarily derived from Asians, to identify genetic vulnerabilities that can be explored as therapeutic targets. We identify known and novel fitness genes and demonstrate that many previously identified OSCC-related cancer genes are non-essential and could have limited therapeutic value, while other fitness genes warrant further investigation for their potential as therapeutic targets. We validate a distinctive dependency on YAP1 and WWTR1 of the Hippo pathway, where the lost-of-fitness effect of one paralog can be compensated only in a subset of lines. We also discover that OSCCs with WWTR1 dependency signature are significantly associated with biomarkers of favourable response towards immunotherapy. In summary, we have delineated the genetic vulnerabilities of OSCC, enabling the prioritization of therapeutic targets for further exploration, including the targeting of YAP1 and WWTR1.

Data availability

All main data generated or analysed during this study are included in the manuscript and supplementary files. Source data files for each figures and supplements have also been provided.The larger datasets of CRISPR screens, WES and RNA-sequencing output are available from Figshare (https://doi.org/10.6084/m9.figshare.11919753).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Annie Wai Yeeng Chai

    Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8015-6050
  2. Pei San Yee

    Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  3. Stacey Price

    Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Shi Mun Yee

    Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  5. Hui Mei Lee

    Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  6. Vivian KH Tiong

    Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya, Malaysia
    Competing interests
    The authors declare that no competing interests exist.
  7. Emanuel Gonçalves

    Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9967-5205
  8. Fiona M Behan

    Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Jessica Bateson

    Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. James Gilbert

    Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Aik Choon Tan

    Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Ultan McDermott

    Oncology R&D, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Mathew J Garnett

    Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Sok Ching Cheong

    Head and Neck Cancer Research Team, Cancer Research Malaysia, Subang Jaya, Malaysia
    For correspondence
    sokching.cheong@cancerresearch.my
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6765-9542

Funding

Medical Research Council (MR/P013457/1)

  • Ultan McDermott
  • Mathew J Garnett
  • Sok Ching Cheong

Wellcome Trust (206194)

  • Stacey Price
  • Emanuel Gonçalves
  • Fiona M Behan
  • Jessica Bateson
  • James Gilbert
  • Mathew J Garnett

Cancer Research Malaysia (-)

  • Annie Wai Yeeng Chai
  • Pei San Yee
  • Shi Mun Yee
  • Hui Mei Lee
  • Vivian KH Tiong
  • Sok Ching Cheong

This work was directly supported by the Newton-Ungku Omar Fund and the Medical Research Council, United Kingdom (MR/P013457/1). Authors in S.C.C.'s group were supported by sponsors of Cancer Research Malaysia; Authors in M.J.G's group were supported by Wellcome. Other funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Chai et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,294
    views
  • 525
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Annie Wai Yeeng Chai
  2. Pei San Yee
  3. Stacey Price
  4. Shi Mun Yee
  5. Hui Mei Lee
  6. Vivian KH Tiong
  7. Emanuel Gonçalves
  8. Fiona M Behan
  9. Jessica Bateson
  10. James Gilbert
  11. Aik Choon Tan
  12. Ultan McDermott
  13. Mathew J Garnett
  14. Sok Ching Cheong
(2020)
Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway
eLife 9:e57761.
https://doi.org/10.7554/eLife.57761

Share this article

https://doi.org/10.7554/eLife.57761

Further reading

    1. Biochemistry and Chemical Biology
    2. Cancer Biology
    Vineeth Vengayil, Shreyas Niphadkar ... Sunil Laxman
    Research Article

    Many cells in high glucose repress mitochondrial respiration, as observed in the Crabtree and Warburg effects. Our understanding of biochemical constraints for mitochondrial activation is limited. Using a Saccharomyces cerevisiae screen, we identified the conserved deubiquitinase Ubp3 (Usp10), as necessary for mitochondrial repression. Ubp3 mutants have increased mitochondrial activity despite abundant glucose, along with decreased glycolytic enzymes, and a rewired glucose metabolic network with increased trehalose production. Utilizing ∆ubp3 cells, along with orthogonal approaches, we establish that the high glycolytic flux in glucose continuously consumes free Pi. This restricts mitochondrial access to inorganic phosphate (Pi), and prevents mitochondrial activation. Contrastingly, rewired glucose metabolism with enhanced trehalose production and reduced GAPDH (as in ∆ubp3 cells) restores Pi. This collectively results in increased mitochondrial Pi and derepression, while restricting mitochondrial Pi transport prevents activation. We therefore suggest that glycolytic flux-dependent intracellular Pi budgeting is a key constraint for mitochondrial repression.

    1. Cancer Biology
    2. Genetics and Genomics
    Joakim W Karlsson, Vasu R Sah ... Jonas A Nilsson
    Research Article

    Uveal melanoma (UM) is a rare melanoma originating in the eye’s uvea, with 50% of patients experiencing metastasis predominantly in the liver. In contrast to cutaneous melanoma, there is only a limited effectiveness of combined immune checkpoint therapies, and half of patients with uveal melanoma metastases succumb to disease within 2 years. This study aimed to provide a path toward enhancing immunotherapy efficacy by identifying and functionally validating tumor-reactive T cells in liver metastases of patients with UM. We employed single-cell RNA-seq of biopsies and tumor-infiltrating lymphocytes (TILs) to identify potential tumor-reactive T cells. Patient-derived xenograft (PDX) models of UM metastases were created from patients, and tumor sphere cultures were generated from these models for co-culture with autologous or MART1-specific HLA-matched allogenic TILs. Activated T cells were subjected to TCR-seq, and the TCRs were matched to those found in single-cell sequencing data from biopsies, expanded TILs, and in livers or spleens of PDX models injected with TILs. Our findings revealed that tumor-reactive T cells resided not only among activated and exhausted subsets of T cells, but also in a subset of cytotoxic effector cells. In conclusion, combining single-cell sequencing and functional analysis provides valuable insights into which T cells in UM may be useful for cell therapy amplification and marker selection.